UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
Q2FZS0 (FABH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Beta-ketoacyl-[acyl-carrier-protein] synthase III; 3-oxoacyl-[acyl-carrier-protein] synthase 3; 3-oxoacyl-[acyl-carrier-protein] synthase III; | |
Q7X2S2 (ARCC2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Carbamate kinase 2; | |
Q2FWC1 (PDP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Pyrimidine-nucleoside phosphorylase; | |
Q2FY06 (ERA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | GTPase Era; | |
Q2G0T0 (RSMA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribosomal RNA small subunit methyltransferase A; 16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase; 16S rRNA dimethyladenosine transferase; 16S rRNA dimethylase; S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase; | |
Q2G1N3 (SBNA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | N-(2-amino-2-carboxyethyl)-L-glutamate synthase; Staphyloferrin B biosynthesis protein SbnA; | |
Q2G1G6 (MURQ_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | N-acetylmuramic acid 6-phosphate etherase; N-acetylmuramic acid 6-phosphate hydrolase; N-acetylmuramic acid 6-phosphate lyase; | |
Q2FW32 (RPOA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | DNA-directed RNA polymerase subunit alpha; RNA polymerase subunit alpha; Transcriptase subunit alpha; | |
Q2FXM7 (ACCA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha; | |
Q2G037 (WHIA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable cell division protein WhiA; | |
Q2FX03 (Y2103_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0421 protein SAOUHSC_02103; | |
Q2G1Q2 (PLC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 1-phosphatidylinositol phosphodiesterase; Phosphatidylinositol diacylglycerol-lyase; Phosphatidylinositol-specific phospholipase C; | |
Q2FYQ5 (NIKB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Nickel import system permease protein NikB; | |
Q2FZ55 (PLSX_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Phosphate acyltransferase; Acyl-ACP phosphotransacylase; Acyl-[acyl-carrier-protein]--phosphate acyltransferase; Phosphate-acyl-ACP acyltransferase; | |
Q2FYP3 (CVFB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Conserved virulence factor B; | |
Q2G035 (Y792_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Epimerase family protein SAOUHSC_00792; | |
Q2FYU4 (GUAC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | GMP reductase; Guanosine 5'-monophosphate oxidoreductase; | |
Q2FXB1 (LUKDV_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Leucotoxin LukDv; Variant of LukD; | |
Q7BHL7 (MSRR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Regulatory protein MsrR; | |
Q2FYP6 (PSTS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Phosphate-binding protein PstS; | |
Q2FZT4 (Y906_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uncharacterized protein SAOUHSC_00906; | |
Q2FVK2 (HLGC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Gamma-hemolysin component C; Leukocidin s subunit; | |
Q2FWZ2 (DAGK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Diacylglycerol kinase; | |
Q2FYZ2 (MIAA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | tRNA dimethylallyltransferase; Dimethylallyl diphosphate:tRNA dimethylallyltransferase; Isopentenyl-diphosphate:tRNA isopentenyltransferase; | |
O33599 (LYTM_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glycyl-glycine endopeptidase LytM; Autolysin LytM; | |
P0A0B9 (LACC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Tagatose-6-phosphate kinase; Phosphotagatokinase; | |
Q2FZA9 (ARCC1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Carbamate kinase 1; | |
Q2FXZ9 (FLOA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Flotillin-like protein FloA; | |
Q2FZ30 (XERC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Tyrosine recombinase XerC; | |
Q2FWP1 (PHLC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Phospholipase C; Beta-hemolysin; Beta-toxin; Sphingomyelinase; | |
Q2G039 (Y787_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Nucleotide-binding protein SAOUHSC_00787; | |
P0A011 (LACD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Tagatose 1,6-diphosphate aldolase; D-tagatose-1,6-bisphosphate aldolase; Tagatose-bisphosphate aldolase; | |
Q2FVK1 (HLGB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Gamma-hemolysin component B; H-gamma-1; H-gamma-I; Leukocidin f subunit; | |
Q2FXZ0 (HRCA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Heat-inducible transcription repressor HrcA; | |
Q2FUS8 (DRP35_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Lactonase drp35; | |
Q2FY16 (END4_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable endonuclease 4; Endodeoxyribonuclease IV; Endonuclease IV; | |
Q2FV17 (ALF1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Fructose-bisphosphate aldolase class 1; Fructose-bisphosphate aldolase class I; | |
Q2FYR7 (TRPD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Anthranilate phosphoribosyltransferase; | |
Q2FYG1 (GPDA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glycerol-3-phosphate dehydrogenase [NAD(P)+]; NAD(P)(+)-dependent glycerol-3-phosphate dehydrogenase; NAD(P)H-dependent dihydroxyacetone-phosphate reductase; | |
Q2FWL6 (REX_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Redox-sensing transcriptional repressor Rex; | |
Q2FVK5 (SBI_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Immunoglobulin-binding protein Sbi; | |
Q2G028 (ENO_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Enolase; 2-phospho-D-glycerate hydro-lyase; 2-phosphoglycerate dehydratase; | |
Q2G0K7 (HPS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 3-hexulose-6-phosphate synthase; D-arabino-3-hexulose-6-phosphate formaldehyde lyase; | |
Q2FZ31 (TRMFO_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO; Folate-dependent tRNA (uracil-5-)-methyltransferase; Folate-dependent tRNA(M-5-U54)-methyltransferase; | |
Q2FYR5 (TRPF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | N-(5'-phosphoribosyl)anthranilate isomerase; | |
Q2FWE6 (UPP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uracil phosphoribosyltransferase; UMP pyrophosphorylase; UPRTase; | |
Q2FVQ2 (Y2650_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uncharacterized lipoprotein SAOUHSC_02650; | |
Q2FX09 (VRAR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Response regulator protein VraR; | |
Q2FYG0 (DER_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | GTPase Der; GTP-binding protein EngA; | |
Q2FXJ0 (MURC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UDP-N-acetylmuramate--L-alanine ligase; UDP-N-acetylmuramoyl-L-alanine synthetase; |
Staphylococcus aureus is a Gram-positive coccal bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin. Although S. aureus is not always pathogenic, it is a common cause of skin infections such as abscesses, respiratory infections such as sinusitis, and food poisoning.
An estimated 20% of the human population are long-term carriers of S. aureus. It is one of the five most common causes of hospital-acquired infections and is often the cause of postsurgical wound infections. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. There are currently (2016) no dedicated antibiotics against drug-resistant S. aureus available.
The genome of S. aureus was first sequenced in 2006.
From left to right: i) The number of proteins in the reference proteome of Staphylococcus aureus, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Staphylococcus aureus for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Staphylococcus aureus, please visit UniProtKB.
You can easily download the latest protein sequences for Staphylococcus aureus proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2025_03 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
2,889 | 2,387 | 3,836 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Staphylococcus aureus reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Staphylococcus aureus proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 12-mer | 13-mer | 14-mer | 24-mer | 25-mer | 40-mer | 60-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,420 | 985 | 84 | 204 | 5 | 76 | 6 | 15 | 3 | 8 | 13 | 3 | 4 | 7 | 1 | 1 | 1 |